Terbinafine: agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001315:Australia; D006801:Humans; D009281:Naphthalenes / Q000009:adverse effects* / Q000627:therapeutic use
D000935:Antifungal Agents; D009281:Naphthalenes